John Walls

19.3k total citations
171 papers, 5.2k citations indexed

About

John Walls is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Clinical Biochemistry. According to data from OpenAlex, John Walls has authored 171 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Nephrology, 24 papers in Pulmonary and Respiratory Medicine and 22 papers in Clinical Biochemistry. Recurrent topics in John Walls's work include Dialysis and Renal Disease Management (35 papers), Metabolism and Genetic Disorders (21 papers) and Chronic Kidney Disease and Diabetes (21 papers). John Walls is often cited by papers focused on Dialysis and Renal Disease Management (35 papers), Metabolism and Genetic Disorders (21 papers) and Chronic Kidney Disease and Diabetes (21 papers). John Walls collaborates with scholars based in United Kingdom, United States and France. John Walls's co-authors include Kevin P.G. Harris, John Feehally, Mustafa Arıcı, Tom Horlick‐Jones, Gene Rowe, Nick Pidgeon, Nigel J. Brunskill, Timothy O’Riordan, Wouter Poortinga and F. Baker and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Kidney International.

In The Last Decade

John Walls

168 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Walls United Kingdom	43	2.0k	753	673	605	557	171	5.2k
Marshall M. Joffe United States	45	2.2k 1.1×	1.0k 1.3×	486 0.7×	130 0.2×	1.1k 1.9×	113	8.5k
Stephen Dunn United States	32	1.2k 0.6×	484 0.6×	1.1k 1.7×	101 0.2×	583 1.0×	69	4.3k
David B. Thomas United States	50	1.5k 0.8×	947 1.3×	1.8k 2.6×	103 0.2×	940 1.7×	222	9.1k
Richard A. Preston United States	33	345 0.2×	400 0.5×	561 0.8×	191 0.3×	545 1.0×	188	4.1k
John S. Gill Canada	44	1.1k 0.5×	2.3k 3.0×	195 0.3×	273 0.5×	1.4k 2.5×	169	7.0k
Robert Gutman United States	22	1.1k 0.6×	400 0.5×	114 0.2×	186 0.3×	224 0.4×	75	2.9k
Roger Williams United Kingdom	52	223 0.1×	2.4k 3.2×	1.2k 1.8×	103 0.2×	629 1.1×	259	8.8k
David J. Kennedy United States	39	561 0.3×	653 0.9×	2.1k 3.2×	89 0.1×	631 1.1×	165	5.5k
Ann E. Clarke Canada	56	277 0.1×	1.5k 2.0×	676 1.0×	118 0.2×	528 0.9×	304	11.2k
Albert B. Lowenfels United States	57	439 0.2×	7.4k 9.8×	2.2k 3.2×	77 0.1×	2.6k 4.7×	161	15.4k

Countries citing papers authored by John Walls

Since Specialization

Citations

This map shows the geographic impact of John Walls's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Walls with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Walls more than expected).

Fields of papers citing papers by John Walls

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Walls. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Walls. The network helps show where John Walls may publish in the future.

Co-authorship network of co-authors of John Walls

This figure shows the co-authorship network connecting the top 25 collaborators of John Walls. A scholar is included among the top collaborators of John Walls based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Walls. John Walls is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arıcı, Mustafa & John Walls. (2001). End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?. Kidney International. 59(2). 407–414. 319 indexed citations

Harris, Kevin P.G., et al.. (2001). Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney International. 59(3). 1128–1133. 133 indexed citations

Thomas, Mark E., Nigel J. Brunskill, Kevin P.G. Harris, et al.. (1999). Proteinuria induces tubular cell turnover: A potential mechanism for tubular atrophy. Kidney International. 55(3). 890–898. 99 indexed citations

Walls, John, et al.. (1998). Does Metabolic Acidosis Have Clinically Important Consequences in Dialysis Patients?. Seminars in Dialysis. 11(1). 18–19. 1 indexed citations

Walls, John, et al.. (1997). New frontiers in continuous ambulatory peritoneal dialysis.. PubMed. 62. S108–10. 3 indexed citations

Viberti, Gian Carlo, S. M. Marshall, Robin N. Beech, et al.. (1996). Report on renal disease in diabetes.. PubMed. 13(9 Suppl 4). S6–12. 16 indexed citations

Harper, Steven J., Keith R. Abrams, Adam Jurewicz, et al.. (1996). The beneficial effects of oral nifedipine on cyclosporin-treated renal transplant recipients ? a randomised prospective study. Transplant International. 9(2). 115–125. 22 indexed citations

Oman, Paul, T. Horsburgh, J. Feehally, et al.. (1992). Is Indian origin a risk factor in cadaveric renal transplantation?. PubMed. 24(5). 1759–1759. 1 indexed citations

Bennett, S.C.J., et al.. (1992). The effects of dopamine and a low protein diet on glomerular filtration rate and renal plasma flow in the aged kidney. European Journal of Clinical Pharmacology. 42(4). 375–378. 4 indexed citations

10.

Harris, Kevin P.G., Jane Hattersley, J. Feehally, & John Walls. (1991). Acute renal failure associated with haematological malignancies: A review of 10 years experience. European Journal Of Haematology. 47(2). 119–122. 18 indexed citations

11.

Andrews, Mark, et al.. (1990). Systemic vasculitis in the 1980s--is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?. PubMed. 24(4). 284–8. 81 indexed citations

12.

Andrews, Mark, et al.. (1990). Systemic Vasculitis in the 1980s—Is There an Increasing Incidence of Wegener's Graanulomatosis and Microscopic Polyarteritis?. Journal of the Royal College of Physicians of London. 24(4). 284–288. 1 indexed citations

13.

Williams, Bryan, P. Burton, J. Feehally, & John Walls. (1989). The Changing Face of End Stage Renal Disease in a UK Renal Unit. Journal of the Royal College of Physicians of London. 23(2). 116–120. 1 indexed citations

14.

Howie, Alexander J., M. Beaman, Clare M. Morland, et al.. (1989). Different types of segmental sclerosing glomerular lesions in six experimental models of proteinuria. The Journal of Pathology. 157(2). 141–151. 48 indexed citations

15.

Ataman, Rezzan, et al.. (1988). Long-term CAPD--some U.K. experience.. PubMed. 30 Suppl 1. S71–5. 10 indexed citations

16.

Harris, Kevin P.G., Ginny Russell, S D Parvin, P S Veitch, & John Walls. (1986). Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.. BMJ. 292(6512). 16–16. 95 indexed citations

17.

Beaman, Miles, et al.. (1985). Convulsions associated with cyclosporin A in renal transplant recipients.. BMJ. 290(6462). 139–140. 49 indexed citations

18.

Williams, Alan J., Beth A. Smith, & John Walls. (1984). End stage renal failure: coping with the demand.. PubMed. 16(1). 1–3. 4 indexed citations

19.

Bennett, S., G. I. Russell, & John Walls. (1983). Low protein diets in uraemia.. BMJ. 287(6402). 1344.2–1345. 15 indexed citations

20.

Walls, John, et al.. (1968). Rectal Bleeding and Indomethacin. BMJ. 2(5596). 52.3–52. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact